Human Papillomavirus Type 16/18 Bivalent Vaccine (Beijing Health Guard Biotechnology)

重组人乳头瘤病毒16/18型二价疫苗 (北京康乐卫士生物技术股份有限公司)

Report date: 2025/10/20 14:38:47

Base Information

Drug NameHuman Papillomavirus Type 16/18 Bivalent Vaccine (Beijing Health Guard Biotechnology)
Drug Alias NamemRNA二价治疗性HPV疫苗 (北京康乐卫士生物技术股份有限公司)
ClassificationCell and gene therapy > Gene therapy > mRNAVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCluster of differentiation 8 activators
TargetsCluster of differentiation 8
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Health Guard Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Health Guard Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A